Text Correction
In the published article, there was an omission in the Acknowledgements section. The classification as part of the doctoral thesis of O. Schleicher was not integrated into the published article.
A correction has been made to Acknowledgments. The paragraph previously stated:
“The continuous financial support in data collection by “Sonnenstrahl e.V. Dresden - Förderkreis für krebskranke Kinder und Jugendliche” (Dresden, Germany), “Schornsteinfeger helfen krebskranken Kindern e.V.” (Dörfles-Esbach, Germany), and the “Madeleine-Schickedanz Kinderkrebsstiftung” (Fürth, Germany) is highly acknowledged.”
The full corrected Acknowledgments appear below:
Acknowledgments
The continuous financial support in data collection by “Sonnenstrahl e.V. Dresden - Förderkreis für krebskranke Kinder und Jugendliche” (Dresden, Germany), “Schornsteinfeger helfen krebskranken Kindern e.V.” (Dörfles-Esbach, Germany), and the “Madeleine-Schickedanz Kinderkrebsstiftung” (Fürth, Germany) is highly acknowledged. The present work was performed by O. Schleicher in fulfillment of the requirements for obtaining the degree “Dr. med.” at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
pediatric CML, HSCT, long-term follow-up, health-related quality of life (HRQoL), Fact-BMT, participant self-reported outcome, cGVHD
Citation
Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, Erdmann F, Karow A, Metzler M and Suttorp M (2022) Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia. Front. Oncol. 12:1116757. doi: 10.3389/fonc.2022.1116757
Received
05 December 2022
Accepted
06 December 2022
Published
15 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Schleicher, Horndasch, Krumbholz, Sembill, Bremensdorfer, Grabow, Erdmann, Karow, Metzler and Suttorp.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Meinolf Suttorp, meinolf.suttorp@uniklinikum-dresden.de
†These authors share senior authorship
This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.